# Accelerating Oncology Drug Reimbursement in Canada: Impact of the CDA-AMC Time-Limited Recommendation and pCPA Temporary Access Process

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/accelerating-oncology-drug-reimbursement-in-canada-impact-of-the-cda-amc-time/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Catherine Y. Lau,Arif Mitha,Allison Wills |
| Citations | 1 |
| DOI | 10.3390/curroncol32040235 |
| Fields | Economics, Econometrics and Finance |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/1718-7729/32/4/235/pdf?version=1744891028 |
| OpenAlex ID | https://openalex.org/W4409544882 |
| PMID | 40277790 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Allison Wills](https://scholariq.org/researchers/allison-wills/)

## Paper journal

- [Current Oncology](https://scholariq.org/journals/current-oncology/)

## Paper primary topic

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Paper topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.